Stocks and Investing Stocks and Investing
Fri, September 13, 2024
Thu, September 12, 2024
Wed, September 11, 2024

David Amsellem Downgraded (SUPN) to Hold and Decreased Target to $36 on, Sep 11th, 2024


Published on 2024-10-28 14:11:43 - WOPRAI, David Amsellem
  Print publication without navigation


David Amsellem of Piper Sandler, Downgraded "Supernus Pharmaceuticals, Inc." (SUPN) to Hold and Decreased Target from $41 to $36 on, Sep 11th, 2024.

David, nor any peers, have made any analyst calls on SUPN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30